Quantification of circulating Epstein–Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-07-11

AUTHORS

Y-L Kwong, A W K Pang, A Y H Leung, C-S Chim, E Tse

ABSTRACT

Circulating Epstein–Barr virus (EBV) DNA is a biomarker of EBV-associated malignancies. Its significance in natural killer/T-cell lymphoma treated with the novel regimen SMILE was investigated. EBV DNA was quantified with a World Health Organization EBV standard in 910 plasma samples collected during 230 courses of SMILE in 56 patients. Median presentation EBV DNA was 1900 (0–1.4 × 107) IU/ml. Presentation EBV DNA was significantly associated with tumor load and treatment response. To examine lymphoma chemosensitivity, EBV DNA changes after SMILE were evaluated. EBV DNA after SMILE (I) significantly correlated with tumor load and treatment response. Two dynamic parameters were further analyzed: negative EBV DNA after SMILE (I) and EBV DNA change patterns during treatment (A: persistently undetectable; B: persistently detectablepresentation). Negative EBV DNA after SMILE (I) and pattern A EBV DNA change significantly correlated with lower tumor load and superior outcome. Multivariate analysis involving presentation features, international prognostic index (IPI), Korean prognostic score and EBV DNA parameters showed that negative EBV DNA after SMILE (I) had the most significant impact (P<0.001) on overall survival and pattern A EBV DNA change had the most significant impact (P=0.002) on disease-free survival. Presentation EBV DNA, IPI and Korean prognostic scores were not independent prognostic factors. More... »

PAGES

865-870

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/leu.2013.212

DOI

http://dx.doi.org/10.1038/leu.2013.212

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1021831640

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23842425


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Asparaginase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dexamethasone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Etoposide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Herpesvirus 4, Human", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ifosfamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Killer Cells, Natural", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma, T-Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methotrexate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kwong", 
        "givenName": "Y-L", 
        "id": "sg:person.01100514066.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100514066.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pang", 
        "givenName": "A W K", 
        "id": "sg:person.015276613022.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015276613022.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leung", 
        "givenName": "A Y H", 
        "id": "sg:person.011121156664.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011121156664.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chim", 
        "givenName": "C-S", 
        "id": "sg:person.0722115232.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722115232.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tse", 
        "givenName": "E", 
        "id": "sg:person.01126550300.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126550300.26"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.leu.2403955", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010474068", 
          "https://doi.org/10.1038/sj.leu.2403955"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-07-11", 
    "datePublishedReg": "2013-07-11", 
    "description": "Circulating Epstein\u2013Barr virus (EBV) DNA is a biomarker of EBV-associated malignancies. Its significance in natural killer/T-cell lymphoma treated with the novel regimen SMILE was investigated. EBV DNA was quantified with a World Health Organization EBV standard in 910 plasma samples collected during 230 courses of SMILE in 56 patients. Median presentation EBV DNA was 1900 (0\u20131.4 \u00d7 107) IU/ml. Presentation EBV DNA was significantly associated with tumor load and treatment response. To examine lymphoma chemosensitivity, EBV DNA changes after SMILE were evaluated. EBV DNA after SMILE (I) significantly correlated with tumor load and treatment response. Two dynamic parameters were further analyzed: negative EBV DNA after SMILE (I) and EBV DNA change patterns during treatment (A: persistently undetectable; B: persistently detectablepresentation). Negative EBV DNA after SMILE (I) and pattern A EBV DNA change significantly correlated with lower tumor load and superior outcome. Multivariate analysis involving presentation features, international prognostic index (IPI), Korean prognostic score and EBV DNA parameters showed that negative EBV DNA after SMILE (I) had the most significant impact (P<0.001) on overall survival and pattern A EBV DNA change had the most significant impact (P=0.002) on disease-free survival. Presentation EBV DNA, IPI and Korean prognostic scores were not independent prognostic factors.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/leu.2013.212", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1097065", 
        "issn": [
          "0887-6924", 
          "1476-5551"
        ], 
        "name": "Leukemia", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "keywords": [
      "negative EBV-DNA", 
      "International Prognostic Index", 
      "Epstein-Barr virus DNA", 
      "EBV DNA", 
      "T-cell lymphoma", 
      "tumor load", 
      "prognostic score", 
      "treatment response", 
      "natural killer/T-cell lymphoma", 
      "NK/T-cell lymphoma", 
      "virus DNA", 
      "low tumor load", 
      "disease-free survival", 
      "independent prognostic factor", 
      "SMILE protocol", 
      "overall survival", 
      "prognostic factors", 
      "prognostic index", 
      "prognostic significance", 
      "IU/", 
      "superior outcomes", 
      "multivariate analysis", 
      "plasma samples", 
      "DNA changes", 
      "lymphoma", 
      "presentation features", 
      "survival", 
      "scores", 
      "DNA parameters", 
      "patients", 
      "malignancy", 
      "chemosensitivity", 
      "EBV", 
      "biomarkers", 
      "response", 
      "outcomes", 
      "smile", 
      "significant impact", 
      "treatment", 
      "significance", 
      "DNA", 
      "changes", 
      "course", 
      "index", 
      "factors", 
      "protocol", 
      "impact", 
      "change patterns", 
      "patterns", 
      "samples", 
      "quantification", 
      "standards", 
      "analysis", 
      "features", 
      "load", 
      "parameters", 
      "dynamic parameters"
    ], 
    "name": "Quantification of circulating Epstein\u2013Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance", 
    "pagination": "865-870", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1021831640"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/leu.2013.212"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23842425"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/leu.2013.212", 
      "https://app.dimensions.ai/details/publication/pub.1021831640"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_602.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/leu.2013.212"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/leu.2013.212'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/leu.2013.212'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/leu.2013.212'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/leu.2013.212'


 

This table displays all metadata directly associated to this object as RDF triples.

226 TRIPLES      21 PREDICATES      102 URIs      93 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/leu.2013.212 schema:about N27e8c0fcc60d446a9dc452588a5e231f
2 N48f49df53d0945298c75182499a4b74e
3 N58c3b3d9fac94d7199484d25ca884528
4 N5e5c37e601f8477cb58f7b55194baf20
5 N64b371f4d4c344419ff1988bc5223a5d
6 N66649c74f7c64beb946ac1d15e0a59ef
7 N6a20c286a54c43ae851542d93b1e5b08
8 N6b5270b4b0f24e99bb7a7f09d9309751
9 N7580537a1a4d45d28444054089e80b87
10 N781742c0673844dcb673a73db59a3024
11 N80d6d3900f8b4fcb8773f885a14e3dbd
12 N850d51b68158406096a20b2f79d41638
13 Naa86776cdf15440fade192ba327746f9
14 Nc027ab1cf960449b92acfe492752831a
15 Nea21a39594b34c729d5ddd86f65e84bc
16 Nf33abab8d9494cafa6f4f1fa2bfccfaa
17 Nf8e9891c083c4d4abf3c339ae2394b99
18 Nfd3795f716dd4c00b72b10bdbe7bbb19
19 Nffa5981a2de54f539907da282a290f5f
20 anzsrc-for:11
21 anzsrc-for:1107
22 schema:author N1689fc123ef04666970035664fbd216c
23 schema:citation sg:pub.10.1038/sj.leu.2403955
24 schema:datePublished 2013-07-11
25 schema:datePublishedReg 2013-07-11
26 schema:description Circulating Epstein–Barr virus (EBV) DNA is a biomarker of EBV-associated malignancies. Its significance in natural killer/T-cell lymphoma treated with the novel regimen SMILE was investigated. EBV DNA was quantified with a World Health Organization EBV standard in 910 plasma samples collected during 230 courses of SMILE in 56 patients. Median presentation EBV DNA was 1900 (0–1.4 × 107) IU/ml. Presentation EBV DNA was significantly associated with tumor load and treatment response. To examine lymphoma chemosensitivity, EBV DNA changes after SMILE were evaluated. EBV DNA after SMILE (I) significantly correlated with tumor load and treatment response. Two dynamic parameters were further analyzed: negative EBV DNA after SMILE (I) and EBV DNA change patterns during treatment (A: persistently undetectable; B: persistently detectable<presentation; C: persistently detectable>presentation). Negative EBV DNA after SMILE (I) and pattern A EBV DNA change significantly correlated with lower tumor load and superior outcome. Multivariate analysis involving presentation features, international prognostic index (IPI), Korean prognostic score and EBV DNA parameters showed that negative EBV DNA after SMILE (I) had the most significant impact (P<0.001) on overall survival and pattern A EBV DNA change had the most significant impact (P=0.002) on disease-free survival. Presentation EBV DNA, IPI and Korean prognostic scores were not independent prognostic factors.
27 schema:genre article
28 schema:isAccessibleForFree false
29 schema:isPartOf N2691a011435344efae75971ad32b126f
30 Na019775cf62a48b398aa021bb3059fac
31 sg:journal.1097065
32 schema:keywords DNA
33 DNA changes
34 DNA parameters
35 EBV
36 EBV DNA
37 Epstein-Barr virus DNA
38 IU/
39 International Prognostic Index
40 NK/T-cell lymphoma
41 SMILE protocol
42 T-cell lymphoma
43 analysis
44 biomarkers
45 change patterns
46 changes
47 chemosensitivity
48 course
49 disease-free survival
50 dynamic parameters
51 factors
52 features
53 impact
54 independent prognostic factor
55 index
56 load
57 low tumor load
58 lymphoma
59 malignancy
60 multivariate analysis
61 natural killer/T-cell lymphoma
62 negative EBV-DNA
63 outcomes
64 overall survival
65 parameters
66 patients
67 patterns
68 plasma samples
69 presentation features
70 prognostic factors
71 prognostic index
72 prognostic score
73 prognostic significance
74 protocol
75 quantification
76 response
77 samples
78 scores
79 significance
80 significant impact
81 smile
82 standards
83 superior outcomes
84 survival
85 treatment
86 treatment response
87 tumor load
88 virus DNA
89 schema:name Quantification of circulating Epstein–Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance
90 schema:pagination 865-870
91 schema:productId N030bf2f8513b4f9facbffcf9a9486b80
92 N810c8a0a51594163af4657687345825c
93 N93c2e88ae7344476bf14b40bec3234d5
94 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021831640
95 https://doi.org/10.1038/leu.2013.212
96 schema:sdDatePublished 2022-11-24T20:57
97 schema:sdLicense https://scigraph.springernature.com/explorer/license/
98 schema:sdPublisher N51a48db0af1d4b1e993e34f5c27d6fe0
99 schema:url https://doi.org/10.1038/leu.2013.212
100 sgo:license sg:explorer/license/
101 sgo:sdDataset articles
102 rdf:type schema:ScholarlyArticle
103 N030bf2f8513b4f9facbffcf9a9486b80 schema:name pubmed_id
104 schema:value 23842425
105 rdf:type schema:PropertyValue
106 N1689fc123ef04666970035664fbd216c rdf:first sg:person.01100514066.14
107 rdf:rest Nbf8c6e1382ba466d9fb5e853660be23f
108 N20967f035d6d40f48104e9c78bcd5184 rdf:first sg:person.011121156664.42
109 rdf:rest N41fc7f33503942b1aba1684361a683c8
110 N2691a011435344efae75971ad32b126f schema:volumeNumber 28
111 rdf:type schema:PublicationVolume
112 N27e8c0fcc60d446a9dc452588a5e231f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Prognosis
114 rdf:type schema:DefinedTerm
115 N2ef419632208430e89f5af0e25bcee16 rdf:first sg:person.01126550300.26
116 rdf:rest rdf:nil
117 N41fc7f33503942b1aba1684361a683c8 rdf:first sg:person.0722115232.29
118 rdf:rest N2ef419632208430e89f5af0e25bcee16
119 N48f49df53d0945298c75182499a4b74e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Etoposide
121 rdf:type schema:DefinedTerm
122 N51a48db0af1d4b1e993e34f5c27d6fe0 schema:name Springer Nature - SN SciGraph project
123 rdf:type schema:Organization
124 N58c3b3d9fac94d7199484d25ca884528 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Lymphoma, T-Cell
126 rdf:type schema:DefinedTerm
127 N5e5c37e601f8477cb58f7b55194baf20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Methotrexate
129 rdf:type schema:DefinedTerm
130 N64b371f4d4c344419ff1988bc5223a5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name DNA, Viral
132 rdf:type schema:DefinedTerm
133 N66649c74f7c64beb946ac1d15e0a59ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Adult
135 rdf:type schema:DefinedTerm
136 N6a20c286a54c43ae851542d93b1e5b08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Herpesvirus 4, Human
138 rdf:type schema:DefinedTerm
139 N6b5270b4b0f24e99bb7a7f09d9309751 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Aged, 80 and over
141 rdf:type schema:DefinedTerm
142 N7580537a1a4d45d28444054089e80b87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Middle Aged
144 rdf:type schema:DefinedTerm
145 N781742c0673844dcb673a73db59a3024 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Antineoplastic Combined Chemotherapy Protocols
147 rdf:type schema:DefinedTerm
148 N80d6d3900f8b4fcb8773f885a14e3dbd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Dexamethasone
150 rdf:type schema:DefinedTerm
151 N810c8a0a51594163af4657687345825c schema:name doi
152 schema:value 10.1038/leu.2013.212
153 rdf:type schema:PropertyValue
154 N850d51b68158406096a20b2f79d41638 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Killer Cells, Natural
156 rdf:type schema:DefinedTerm
157 N93c2e88ae7344476bf14b40bec3234d5 schema:name dimensions_id
158 schema:value pub.1021831640
159 rdf:type schema:PropertyValue
160 Na019775cf62a48b398aa021bb3059fac schema:issueNumber 4
161 rdf:type schema:PublicationIssue
162 Naa86776cdf15440fade192ba327746f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Aged
164 rdf:type schema:DefinedTerm
165 Nbf8c6e1382ba466d9fb5e853660be23f rdf:first sg:person.015276613022.70
166 rdf:rest N20967f035d6d40f48104e9c78bcd5184
167 Nc027ab1cf960449b92acfe492752831a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Male
169 rdf:type schema:DefinedTerm
170 Nea21a39594b34c729d5ddd86f65e84bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Asparaginase
172 rdf:type schema:DefinedTerm
173 Nf33abab8d9494cafa6f4f1fa2bfccfaa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Humans
175 rdf:type schema:DefinedTerm
176 Nf8e9891c083c4d4abf3c339ae2394b99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Female
178 rdf:type schema:DefinedTerm
179 Nfd3795f716dd4c00b72b10bdbe7bbb19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Adolescent
181 rdf:type schema:DefinedTerm
182 Nffa5981a2de54f539907da282a290f5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Ifosfamide
184 rdf:type schema:DefinedTerm
185 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
186 schema:name Medical and Health Sciences
187 rdf:type schema:DefinedTerm
188 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
189 schema:name Immunology
190 rdf:type schema:DefinedTerm
191 sg:journal.1097065 schema:issn 0887-6924
192 1476-5551
193 schema:name Leukemia
194 schema:publisher Springer Nature
195 rdf:type schema:Periodical
196 sg:person.01100514066.14 schema:affiliation grid-institutes:grid.415550.0
197 schema:familyName Kwong
198 schema:givenName Y-L
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100514066.14
200 rdf:type schema:Person
201 sg:person.011121156664.42 schema:affiliation grid-institutes:grid.415550.0
202 schema:familyName Leung
203 schema:givenName A Y H
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011121156664.42
205 rdf:type schema:Person
206 sg:person.01126550300.26 schema:affiliation grid-institutes:grid.415550.0
207 schema:familyName Tse
208 schema:givenName E
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126550300.26
210 rdf:type schema:Person
211 sg:person.015276613022.70 schema:affiliation grid-institutes:grid.415550.0
212 schema:familyName Pang
213 schema:givenName A W K
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015276613022.70
215 rdf:type schema:Person
216 sg:person.0722115232.29 schema:affiliation grid-institutes:grid.415550.0
217 schema:familyName Chim
218 schema:givenName C-S
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722115232.29
220 rdf:type schema:Person
221 sg:pub.10.1038/sj.leu.2403955 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010474068
222 https://doi.org/10.1038/sj.leu.2403955
223 rdf:type schema:CreativeWork
224 grid-institutes:grid.415550.0 schema:alternateName Department of Medicine, Queen Mary Hospital, Hong Kong, China
225 schema:name Department of Medicine, Queen Mary Hospital, Hong Kong, China
226 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...